Vaccine Maker Earned Record Profits but Delivered Disappointment in Return
Emergent BioSolutions was awarded a $628 million federal contract with no competitive bidding. Top executives received big bonuses while factories mostly sat idle and tens of millions of Covid-19 doses were thrown away.
View original article
Contributor: Sharon LaFraniere, Chris Hamby and Rebecca R. Ruiz
